nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonordefrin—SLC6A2—locus ceruleus—Alzheimer's disease	0.146	0.395	CbGeAlD
Levonordefrin—SLC6A2—forebrain—Alzheimer's disease	0.0181	0.0489	CbGeAlD
Levonordefrin—ADRA1A—forebrain—Alzheimer's disease	0.0168	0.0455	CbGeAlD
Levonordefrin—SLC6A2—telencephalon—Alzheimer's disease	0.0167	0.045	CbGeAlD
Levonordefrin—ADRA1A—telencephalon—Alzheimer's disease	0.0155	0.0418	CbGeAlD
Levonordefrin—ADRA2C—telencephalon—Alzheimer's disease	0.0148	0.0398	CbGeAlD
Levonordefrin—ADRA2A—forebrain—Alzheimer's disease	0.0128	0.0346	CbGeAlD
Levonordefrin—ADRA2A—telencephalon—Alzheimer's disease	0.0118	0.0318	CbGeAlD
Levonordefrin—SLC6A2—nervous system—Alzheimer's disease	0.00984	0.0265	CbGeAlD
Levonordefrin—Dopamine—MAOB—Alzheimer's disease	0.0095	0.376	CrCbGaD
Levonordefrin—SLC6A2—central nervous system—Alzheimer's disease	0.00947	0.0256	CbGeAlD
Levonordefrin—ADRA1A—nervous system—Alzheimer's disease	0.00914	0.0247	CbGeAlD
Levonordefrin—ADRA1A—central nervous system—Alzheimer's disease	0.0088	0.0238	CbGeAlD
Levonordefrin—ADRA2C—nervous system—Alzheimer's disease	0.00871	0.0235	CbGeAlD
Levonordefrin—ADRA1A—cerebellum—Alzheimer's disease	0.0086	0.0232	CbGeAlD
Levonordefrin—ADRA2C—central nervous system—Alzheimer's disease	0.00839	0.0226	CbGeAlD
Levonordefrin—ADRA2C—cerebellum—Alzheimer's disease	0.0082	0.0221	CbGeAlD
Levonordefrin—SLC6A2—brain—Alzheimer's disease	0.00752	0.0203	CbGeAlD
Levonordefrin—ADRA1A—brain—Alzheimer's disease	0.00699	0.0189	CbGeAlD
Levonordefrin—ADRA2A—nervous system—Alzheimer's disease	0.00695	0.0188	CbGeAlD
Levonordefrin—ADRA2A—central nervous system—Alzheimer's disease	0.00669	0.0181	CbGeAlD
Levonordefrin—ADRA2C—brain—Alzheimer's disease	0.00666	0.018	CbGeAlD
Levonordefrin—ADRA2A—cerebellum—Alzheimer's disease	0.00654	0.0177	CbGeAlD
Levonordefrin—ADRA2A—brain—Alzheimer's disease	0.00531	0.0143	CbGeAlD
Levonordefrin—Epinephrine—TNF—Alzheimer's disease	0.00521	0.206	CrCbGaD
Levonordefrin—Dopamine—SLC6A4—Alzheimer's disease	0.0043	0.17	CrCbGaD
Levonordefrin—L-DOPA—CYP2D6—Alzheimer's disease	0.00325	0.129	CrCbGaD
Levonordefrin—Dopamine—CYP2D6—Alzheimer's disease	0.00302	0.119	CrCbGaD
Levonordefrin—ADRA2C—Signaling by GPCR—HTR2A—Alzheimer's disease	0.00026	0.00043	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CALM1—Alzheimer's disease	0.00026	0.00043	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ABCA1—Alzheimer's disease	0.00026	0.00043	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—GSK3A—Alzheimer's disease	0.000258	0.000428	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—NOS3—Alzheimer's disease	0.000256	0.000424	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000256	0.000423	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NPS—Alzheimer's disease	0.000255	0.000422	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—A2M—Alzheimer's disease	0.000254	0.000421	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—APP—Alzheimer's disease	0.000254	0.00042	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000254	0.00042	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—F2—Alzheimer's disease	0.000251	0.000415	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000251	0.000415	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PTK2B—Alzheimer's disease	0.00025	0.000414	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.00025	0.000414	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PTGS1—Alzheimer's disease	0.000248	0.00041	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ENO1—Alzheimer's disease	0.000248	0.00041	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PSEN2—Alzheimer's disease	0.000246	0.000408	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000245	0.000406	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—F2—Alzheimer's disease	0.000244	0.000404	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NPY—Alzheimer's disease	0.000244	0.000404	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NTRK2—Alzheimer's disease	0.000244	0.000403	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—GAB2—Alzheimer's disease	0.000244	0.000403	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—SST—Alzheimer's disease	0.000244	0.000403	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—VEGFA—Alzheimer's disease	0.000243	0.000403	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP2D6—Alzheimer's disease	0.000243	0.000402	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CALM1—Alzheimer's disease	0.000243	0.000401	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IAPP—Alzheimer's disease	0.000242	0.000401	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—GSK3A—Alzheimer's disease	0.000241	0.0004	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PLCB1—Alzheimer's disease	0.00024	0.000397	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000238	0.000393	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—APP—Alzheimer's disease	0.000237	0.000393	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CRH—Alzheimer's disease	0.000235	0.00039	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000233	0.000385	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CCR5—Alzheimer's disease	0.000232	0.000384	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—BCHE—Alzheimer's disease	0.000231	0.000382	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	0.000229	0.000378	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—F2—Alzheimer's disease	0.000228	0.000377	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000228	0.000377	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—VEGFA—Alzheimer's disease	0.000227	0.000376	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000227	0.000376	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NPY—Alzheimer's disease	0.000227	0.000375	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IAPP—Alzheimer's disease	0.000225	0.000373	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PLCB1—Alzheimer's disease	0.000224	0.000371	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PPARGC1A—Alzheimer's disease	0.000224	0.00037	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NGFR—Alzheimer's disease	0.000224	0.00037	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—TGFB1—Alzheimer's disease	0.000223	0.00037	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NPS—Alzheimer's disease	0.000223	0.000369	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—HMOX1—Alzheimer's disease	0.000223	0.000369	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CREB1—Alzheimer's disease	0.000222	0.000368	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000222	0.000368	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—F2—Alzheimer's disease	0.000219	0.000363	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PTK2B—Alzheimer's disease	0.000219	0.000362	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CRH—Alzheimer's disease	0.000219	0.000362	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ADAM10—Alzheimer's disease	0.000218	0.000362	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PLCB1—Alzheimer's disease	0.000218	0.00036	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CCL2—Alzheimer's disease	0.000217	0.00036	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CCR5—Alzheimer's disease	0.000216	0.000357	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GAB2—Alzheimer's disease	0.000213	0.000352	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SST—Alzheimer's disease	0.000213	0.000352	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NTRK2—Alzheimer's disease	0.000213	0.000352	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CALM1—Alzheimer's disease	0.000212	0.000351	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000211	0.000349	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GSK3A—Alzheimer's disease	0.000211	0.000349	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ABCA1—Alzheimer's disease	0.000211	0.000349	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NGFR—Alzheimer's disease	0.000209	0.000346	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—TGFB1—Alzheimer's disease	0.000209	0.000345	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CREB1—Alzheimer's disease	0.000208	0.000344	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—APP—Alzheimer's disease	0.000207	0.000343	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NPS—Alzheimer's disease	0.000207	0.000343	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—S100B—Alzheimer's disease	0.000207	0.000342	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000206	0.000341	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ADAM10—Alzheimer's disease	0.000204	0.000338	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—F2—Alzheimer's disease	0.000204	0.000337	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—LPL—Alzheimer's disease	0.000204	0.000337	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PTK2B—Alzheimer's disease	0.000203	0.000337	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CCL2—Alzheimer's disease	0.000203	0.000336	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—F2—Alzheimer's disease	0.000199	0.00033	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NTRK2—Alzheimer's disease	0.000198	0.000327	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GAB2—Alzheimer's disease	0.000198	0.000327	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SST—Alzheimer's disease	0.000198	0.000327	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CALM1—Alzheimer's disease	0.000197	0.000326	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IGF2—Alzheimer's disease	0.000197	0.000326	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GSK3A—Alzheimer's disease	0.000196	0.000325	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PLCB1—Alzheimer's disease	0.000196	0.000324	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—S100B—Alzheimer's disease	0.000193	0.000319	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—APP—Alzheimer's disease	0.000193	0.000319	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IGF1R—Alzheimer's disease	0.00019	0.000315	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—F2—Alzheimer's disease	0.000185	0.000306	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—VEGFA—Alzheimer's disease	0.000185	0.000306	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—TP53—Alzheimer's disease	0.000184	0.000304	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IGF2—Alzheimer's disease	0.000184	0.000304	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—MTHFR—Alzheimer's disease	0.000183	0.000304	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NGFR—Alzheimer's disease	0.000183	0.000302	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—LPL—Alzheimer's disease	0.000182	0.000302	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PLCB1—Alzheimer's disease	0.000182	0.000301	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PPARGC1A—Alzheimer's disease	0.000182	0.000301	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CREB1—Alzheimer's disease	0.000181	0.0003	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—HMOX1—Alzheimer's disease	0.000181	0.000299	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MEF2C—Alzheimer's disease	0.000181	0.000299	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ADAM10—Alzheimer's disease	0.000178	0.000295	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IGF1R—Alzheimer's disease	0.000178	0.000294	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CCL2—Alzheimer's disease	0.000178	0.000294	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PRKCG—Alzheimer's disease	0.000177	0.000293	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NGF—Alzheimer's disease	0.000173	0.000286	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—TP53—Alzheimer's disease	0.000172	0.000284	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CALM1—Alzheimer's disease	0.000171	0.000284	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—APOE—Alzheimer's disease	0.000171	0.000283	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—LPL—Alzheimer's disease	0.00017	0.000282	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NGFR—Alzheimer's disease	0.00017	0.000281	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—TGFB1—Alzheimer's disease	0.000169	0.00028	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CAV1—Alzheimer's disease	0.000169	0.00028	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MEF2C—Alzheimer's disease	0.000169	0.000279	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—S100B—Alzheimer's disease	0.000169	0.000279	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CREB1—Alzheimer's disease	0.000169	0.000279	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CCR5—Alzheimer's disease	0.000168	0.000278	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	0.000166	0.000274	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PRKCG—Alzheimer's disease	0.000166	0.000274	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—LPL—Alzheimer's disease	0.000165	0.000274	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	0.000165	0.000273	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HTR2A—Alzheimer's disease	0.000164	0.000272	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NGF—Alzheimer's disease	0.000161	0.000267	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IGF2—Alzheimer's disease	0.000161	0.000266	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CCR5—Alzheimer's disease	0.000157	0.00026	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	0.000157	0.000259	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IGF1R—Alzheimer's disease	0.000155	0.000257	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—AKT1—Alzheimer's disease	0.000155	0.000257	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HTR2A—Alzheimer's disease	0.000154	0.000254	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CALM1—Alzheimer's disease	0.000153	0.000254	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—LEP—Alzheimer's disease	0.000153	0.000253	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—APOE—Alzheimer's disease	0.000153	0.000253	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CAV1—Alzheimer's disease	0.000151	0.000251	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	0.000149	0.000247	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	0.000149	0.000247	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	0.000149	0.000246	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PPARG—Alzheimer's disease	0.000149	0.000246	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	0.000148	0.000244	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ESR1—Alzheimer's disease	0.000146	0.000242	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—INS—Alzheimer's disease	0.000146	0.000241	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—AKT1—Alzheimer's disease	0.000145	0.00024	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	0.000145	0.00024	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	0.000144	0.000239	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—F2—Alzheimer's disease	0.000144	0.000239	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CALM1—Alzheimer's disease	0.000143	0.000237	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—LEP—Alzheimer's disease	0.000143	0.000236	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—APOE—Alzheimer's disease	0.000143	0.000236	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CAV1—Alzheimer's disease	0.000141	0.000234	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000141	0.000233	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	0.000141	0.000233	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—TP53—Alzheimer's disease	0.000139	0.000231	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CALM1—Alzheimer's disease	0.000139	0.00023	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—APOE—Alzheimer's disease	0.000139	0.00023	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	0.000138	0.000229	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CAV1—Alzheimer's disease	0.000137	0.000227	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	0.000137	0.000227	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	0.000137	0.000227	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ESR1—Alzheimer's disease	0.000136	0.000226	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—F2—Alzheimer's disease	0.000135	0.000223	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	0.000135	0.000223	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	0.000134	0.000222	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—GSK3B—Alzheimer's disease	0.000132	0.000219	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000132	0.000218	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CREB1—Alzheimer's disease	0.000131	0.000217	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	0.000131	0.000217	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—INS—Alzheimer's disease	0.000131	0.000216	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CCL2—Alzheimer's disease	0.000128	0.000213	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—NOS3—Alzheimer's disease	0.000128	0.000212	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	0.000127	0.000211	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IGF1—Alzheimer's disease	0.000126	0.000209	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	0.000125	0.000207	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	0.000125	0.000207	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	0.000125	0.000207	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	0.000125	0.000206	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	0.000124	0.000205	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—GSK3B—Alzheimer's disease	0.000124	0.000205	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CREB1—Alzheimer's disease	0.000123	0.000203	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—INS—Alzheimer's disease	0.000122	0.000202	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PPARG—Alzheimer's disease	0.000121	0.0002	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CCL2—Alzheimer's disease	0.00012	0.000199	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	0.000119	0.000197	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—INS—Alzheimer's disease	0.000118	0.000196	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IGF1—Alzheimer's disease	0.000118	0.000195	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	0.000118	0.000195	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	0.000118	0.000195	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PTGS2—Alzheimer's disease	0.000117	0.000194	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	0.000116	0.000193	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	0.000116	0.000192	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	0.000116	0.000192	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000115	0.000191	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	0.000115	0.00019	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	0.000114	0.00019	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	0.000111	0.000183	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	0.000109	0.000181	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	0.000108	0.000179	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	0.000107	0.000177	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000107	0.000177	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	0.000107	0.000177	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	0.000107	0.000176	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	0.000105	0.000174	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—NOS3—Alzheimer's disease	0.000104	0.000172	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	0.000103	0.000171	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	0.0001	0.000166	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	9.96e-05	0.000165	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	9.91e-05	0.000164	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	9.81e-05	0.000162	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	9.75e-05	0.000161	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	9.72e-05	0.000161	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	9.66e-05	0.00016	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	9.58e-05	0.000159	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	9.5e-05	0.000157	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	9.35e-05	0.000155	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	9.16e-05	0.000152	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	9.08e-05	0.00015	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	9.02e-05	0.000149	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	8.93e-05	0.000148	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	8.91e-05	0.000147	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	8.69e-05	0.000144	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	8.35e-05	0.000138	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	8.32e-05	0.000138	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	8.25e-05	0.000137	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	8.01e-05	0.000133	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	7.94e-05	0.000131	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	7.89e-05	0.000131	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	7.71e-05	0.000128	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	7.57e-05	0.000125	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	7.44e-05	0.000123	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	7.38e-05	0.000122	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	7.33e-05	0.000121	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	7.3e-05	0.000121	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	7.28e-05	0.00012	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	7.07e-05	0.000117	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	6.78e-05	0.000112	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	6.76e-05	0.000112	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	6.74e-05	0.000111	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	6.26e-05	0.000104	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	6.23e-05	0.000103	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	6.18e-05	0.000102	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—AKT1—Alzheimer's disease	5.88e-05	9.73e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	5.82e-05	9.64e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	5.74e-05	9.51e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	5.71e-05	9.44e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	5.33e-05	8.82e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	5.26e-05	8.71e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	5.09e-05	8.42e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	4.92e-05	8.14e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—AKT1—Alzheimer's disease	4.78e-05	7.9e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	4.73e-05	7.83e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	4.66e-05	7.71e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	4.33e-05	7.16e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	4.3e-05	7.11e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	3.99e-05	6.61e-05	CbGpPWpGaD
